S&P 500   3,663.34 (+0.02%)
DOW   29,817.82 (-0.02%)
QQQ   303.64 (+0.06%)
AAPL   122.98 (+0.21%)
MSFT   214.02 (-1.01%)
FB   288.70 (+0.75%)
GOOGL   1,820.73 (+1.41%)
AMZN   3,214.30 (-0.18%)
TSLA   562.64 (-3.78%)
NVDA   541.63 (+1.13%)
BABA   261.88 (-0.81%)
CGC   28.13 (+5.55%)
GE   10.39 (+2.36%)
MU   68.90 (+2.71%)
AMD   94.54 (+2.06%)
T   28.99 (+0.42%)
NIO   46.07 (+1.57%)
F   9.20 (-0.43%)
ACB   10.72 (+9.95%)
NFLX   503.17 (-0.28%)
BA   218.91 (+2.77%)
GILD   61.40 (+0.46%)
DIS   152.00 (+1.71%)
S&P 500   3,663.34 (+0.02%)
DOW   29,817.82 (-0.02%)
QQQ   303.64 (+0.06%)
AAPL   122.98 (+0.21%)
MSFT   214.02 (-1.01%)
FB   288.70 (+0.75%)
GOOGL   1,820.73 (+1.41%)
AMZN   3,214.30 (-0.18%)
TSLA   562.64 (-3.78%)
NVDA   541.63 (+1.13%)
BABA   261.88 (-0.81%)
CGC   28.13 (+5.55%)
GE   10.39 (+2.36%)
MU   68.90 (+2.71%)
AMD   94.54 (+2.06%)
T   28.99 (+0.42%)
NIO   46.07 (+1.57%)
F   9.20 (-0.43%)
ACB   10.72 (+9.95%)
NFLX   503.17 (-0.28%)
BA   218.91 (+2.77%)
GILD   61.40 (+0.46%)
DIS   152.00 (+1.71%)
S&P 500   3,663.34 (+0.02%)
DOW   29,817.82 (-0.02%)
QQQ   303.64 (+0.06%)
AAPL   122.98 (+0.21%)
MSFT   214.02 (-1.01%)
FB   288.70 (+0.75%)
GOOGL   1,820.73 (+1.41%)
AMZN   3,214.30 (-0.18%)
TSLA   562.64 (-3.78%)
NVDA   541.63 (+1.13%)
BABA   261.88 (-0.81%)
CGC   28.13 (+5.55%)
GE   10.39 (+2.36%)
MU   68.90 (+2.71%)
AMD   94.54 (+2.06%)
T   28.99 (+0.42%)
NIO   46.07 (+1.57%)
F   9.20 (-0.43%)
ACB   10.72 (+9.95%)
NFLX   503.17 (-0.28%)
BA   218.91 (+2.77%)
GILD   61.40 (+0.46%)
DIS   152.00 (+1.71%)
S&P 500   3,663.34 (+0.02%)
DOW   29,817.82 (-0.02%)
QQQ   303.64 (+0.06%)
AAPL   122.98 (+0.21%)
MSFT   214.02 (-1.01%)
FB   288.70 (+0.75%)
GOOGL   1,820.73 (+1.41%)
AMZN   3,214.30 (-0.18%)
TSLA   562.64 (-3.78%)
NVDA   541.63 (+1.13%)
BABA   261.88 (-0.81%)
CGC   28.13 (+5.55%)
GE   10.39 (+2.36%)
MU   68.90 (+2.71%)
AMD   94.54 (+2.06%)
T   28.99 (+0.42%)
NIO   46.07 (+1.57%)
F   9.20 (-0.43%)
ACB   10.72 (+9.95%)
NFLX   503.17 (-0.28%)
BA   218.91 (+2.77%)
GILD   61.40 (+0.46%)
DIS   152.00 (+1.71%)
Log in
NYSE:STE

STERIS Stock Forecast, Price & News

$193.49
-0.44 (-0.23 %)
(As of 12/2/2020 12:46 PM ET)
Add
Compare
Today's Range
$191.54
Now: $193.49
$194.27
50-Day Range
$176.38
MA: $187.55
$196.05
52-Week Range
$105.69
Now: $193.49
$196.80
Volume3,284 shs
Average Volume570,297 shs
Market Capitalization$16.51 billion
P/E Ratio40.23
Dividend Yield0.83%
Beta0.66
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The company was founded in 1985 and is based in Dublin, Ireland.
STERIS logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.95 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP85915210
Phone353-1232-2000
Employees13,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.03 billion
Cash Flow$8.32 per share
Book Value$40.17 per share

Profitability

Net Income$407.61 million

Miscellaneous

Market Cap$16.51 billion
Next Earnings Date2/8/2021 (Estimated)
OptionableOptionable
$193.49
-0.44 (-0.23 %)
(As of 12/2/2020 12:46 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











STERIS (NYSE:STE) Frequently Asked Questions

How has STERIS's stock been impacted by COVID-19?

STERIS's stock was trading at $145.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, STE shares have increased by 33.3% and is now trading at $193.66.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of STERIS?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for STERIS
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than STERIS?

Wall Street analysts have given STERIS a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but STERIS wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is STERIS's next earnings date?

STERIS is scheduled to release its next quarterly earnings announcement on Monday, February 8th 2021.
View our earnings forecast for STERIS
.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) issued its earnings results on Monday, November, 2nd. The medical equipment provider reported $1.48 EPS for the quarter, beating the consensus estimate of $1.27 by $0.21. The medical equipment provider earned $756.13 million during the quarter, compared to analysts' expectations of $719.54 million. STERIS had a return on equity of 16.24% and a net margin of 13.69%. The company's quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.32 earnings per share.
View STERIS's earnings history
.

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS declared a quarterly dividend on Monday, November 2nd. Stockholders of record on Tuesday, November 24th will be paid a dividend of $0.40 per share on Friday, December 18th. This represents a $1.60 annualized dividend and a dividend yield of 0.83%. The ex-dividend date is Monday, November 23rd.
View STERIS's dividend history
.

What price target have analysts set for STE?

4 equities research analysts have issued 12 month price objectives for STERIS's shares. Their forecasts range from $200.00 to $200.00. On average, they anticipate STERIS's share price to reach $200.00 in the next year. This suggests a possible upside of 3.3% from the stock's current price.
View analysts' price targets for STERIS
.

Are investors shorting STERIS?

STERIS saw a drop in short interest during the month of October. As of October 30th, there was short interest totaling 907,000 shares, a drop of 21.8% from the October 15th total of 1,160,000 shares. Based on an average daily volume of 409,900 shares, the days-to-cover ratio is presently 2.2 days.
View STERIS's Short Interest
.

Who are some of STERIS's key competitors?

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), The Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

Who are STERIS's key executives?

STERIS's management team includes the following people:
  • Mr. Walter M. Rosebrough Jr., CEO, Pres & Director (Age 66, Pay $2.49M)
  • Mr. Michael J. Tokich, Sr. VP & CFO (Age 51, Pay $1.08M)
  • Mr. Daniel A. Carestio, Sr. VP & Chief Operating Officer (Age 47, Pay $1.09M)
  • Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. (Age 53, Pay $760.33k)
  • Mr. Cary L. Majors, Sr. VP of North America Commercial Operations (Age 45, Pay $690.69k)
  • Ms. Karen L. Burton, Chief Accounting Officer, VP & Controller (Age 52)
  • Julie Winter, Sr. Director of Investor Relations and Corp. Communications
  • Mr. Sudhir K. Pahwa, Sr. VP of Infection Prevention Technologies (Age 67)
  • Stephen Norton, Sr. Director of Corp. Communications
  • Mr. Renato G. Tamaro, VP & Corp. Treasurer (Age 51)

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are STERIS's major shareholders?

STERIS's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.87%), WCM Investment Management LLC (7.61%), State Street Corp (4.37%), Massachusetts Financial Services Co. MA (3.54%), William Blair Investment Management LLC (1.46%) and ArrowMark Colorado Holdings LLC (1.19%). Company insiders that own STERIS stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden, Richard Martin Steeves and Walter M Rosebrough Jr.
View institutional ownership trends for STERIS
.

Which major investors are selling STERIS stock?

STE stock was sold by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, Morgan Stanley, Great Lakes Advisors LLC, Fisher Asset Management LLC, First Trust Advisors LP, AXA S.A., Robeco Institutional Asset Management B.V., and State Street Corp. Company insiders that have sold STERIS company stock in the last year include Cary L Majors, Daniel A Carestio, John Adam Zangerle, Karen L Burton, Mohsen Sohi, Richard C Breeden, Richard Martin Steeves, and Walter M Rosebrough Jr.
View insider buying and selling activity for STERIS
.

Which major investors are buying STERIS stock?

STE stock was bought by a variety of institutional investors in the last quarter, including Polar Capital LLP, Polar Capital LLP, Massachusetts Financial Services Co. MA, WCM Investment Management LLC, Williams Jones Wealth Management LLC., JPMorgan Chase & Co., Great West Life Assurance Co. Can, and Great West Life Assurance Co. Can.
View insider buying and selling activity for STERIS
.

How do I buy shares of STERIS?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $193.66.

How big of a company is STERIS?

STERIS has a market capitalization of $16.52 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. STERIS employs 13,000 workers across the globe.

What is STERIS's official website?

The official website for STERIS is www.steris.com.

How can I contact STERIS?

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.